Seeds Investor’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.02M Buy
2,515
+553
+28% +$565K 0.31% 79
2026
Q1
$1.81M Buy
1,962
+239
+14% +$242K 0.25% 76
2025
Q4
$1.85M Buy
1,723
+342
+25% +$327K 0.35% 51
2025
Q3
$1.05M Sell
1,381
-17
-1% -$12.7K 0.22% 76
2025
Q2
$1.09M Sell
1,398
-219
-14% -$170K 0.26% 62
2025
Q1
$1.34M Sell
1,617
-29
-2% -$24.1K 0.37% 44
2024
Q4
$1.27M Sell
1,646
-66
-4% -$54.6K 0.36% 45
2024
Q3
$1.52M Buy
1,712
+812
+90% +$730K 0.57% 24
2024
Q2
$814K Buy
900
+342
+61% +$274K 0.42% 44
2024
Q1
$434K Buy
+558
New +$397K 0.4% 69

Other funds holding LLY

Seeds Investor's LLY Position: Q2 2026 in Review

Seeds Investor increased its Eli Lilly (LLY) stake by 28% in Q2 2026, buying an estimated $565K and bringing the position to 2,515 shares worth $3.02M. The position accounts for 0.31% of the portfolio, ranked #79.

Seeds Investor first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Seeds Investor held 2,515 shares of Eli Lilly worth $3.02M as of Q2 2026.
  • Seeds Investor bought 553 Eli Lilly shares in Q2 2026, an estimated $565K.
  • Eli Lilly made up 0.31% of Seeds Investor's portfolio in Q2 2026, its #79 holding.
  • Seeds Investor first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Seeds Investor's 13F filing for Q2 2026, filed 12 Aug 2026.